Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MS4A2 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-14 |
mRNA | OSCAR | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-14 |
mRNA | HBQ1 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-14 |
mRNA | KLF1 | CCLE | pan-cancer | AAC | 0.36 | 7e-14 |
mRNA | C7orf34 | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-14 |
mRNA | TUBB1 | GDSC1000 | pan-cancer | AAC | 0.26 | 7e-14 |
mRNA | RREB1 | CCLE | pan-cancer | AAC | 0.39 | 8e-14 |
mRNA | APOL4 | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-14 |
mRNA | ZNF648 | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-14 |
mRNA | SLC25A37 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-13 |